Document:

Exhibit 10.7

 

INNOVATUS LIFE SCIENCES ACQUISITION CORP.

777 Third Avenue, 25th
Floor

New York, NY 10017

 

[       ],
2021

 

Innovatus Life Sciences Acquisition Sponsor, LLC

777 Third Avenue, 25th Floor

New York, NY 10017

 

Re: Administrative Services Agreement

 

Ladies and Gentlemen:

 

This letter agreement (this “Agreement”)
by and between Innovatus Life Sciences Acquisition Corp. (the “Company”) and Innovatus Life Sciences Acquisition Sponsor,
LLC (the “Sponsor”), dated as of the date hereof, will confirm our agreement that, commencing on the date the securities
of the Company are first listed on The Nasdaq Capital Market (the “Listing Date”), pursuant to a Registration Statement
on Form S-1 and prospectus filed with the Securities and Exchange Commission (the “Registration Statement”) and
continuing until the earlier of the consummation by the Company of an initial business combination or the Company’s liquidation
(in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the “Termination Date”):

 

1.             The
Sponsor shall make available, or cause to be made available, to the Company, at 777 Third Avenue, 25th Floor, New York, NY
10017 (or any successor location), office space and secretarial and administrative services as may be reasonably required by the Company.
In exchange therefor, the Company shall pay the Sponsor $10,000 per month on the Listing Date and continuing monthly thereafter until
the Termination Date; and

 

2.             The
Sponsor hereby irrevocably waives any and all right, title, interest, causes of action and claims of any kind as a result of, or arising
out of, this Agreement (each, a “Claim”) in or to, and any and all right to seek payment of any amounts due to it out
of, the trust account established for the benefit of the public stockholders of the Company and into which substantially all of the proceeds
of the Company’s initial public offering will be deposited (the “Trust Account”), and hereby irrevocably waives
any Claim it may have in the future as a result of, or arising out of, this Agreement, which Claim would reduce, encumber or otherwise
adversely affect the Trust Account or any monies or other assets in the Trust Account, and further agrees not to seek recourse, reimbursement,
payment or satisfaction of any Claim against the Trust Account or any monies or other assets in the Trust Account for any reason whatsoever.

 

This Agreement constitutes the entire agreement
and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements, or representations
by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions
contemplated hereby.

 

This Agreement may not be amended, modified or
waived as to any particular provision, except by a written instrument executed by the parties hereto.

 

No party hereto may assign either this Agreement
or any of its rights, interests, or obligations hereunder without the prior written approval of the other party. Any purported assignment
in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the
purported assignee.

 

This Agreement constitutes the entire relationship
of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed
by, construed in accordance with, and interpreted pursuant to the laws of the State of New York.

 

[Signature Page Follows]

 

     

     

    

 

	 	
    Very truly yours,

     

    INNOVATUS LIFE SCIENCES ACQUISITION CORP.

	 	 
	 	By:	 
	 	 	Name: David Schiff
	 	 	Title: Chief Executive Officer

 

	
    AGREED AND ACCEPTED BY:

     

    INNOVATUS LIFE SCIENCES ACQUISITION SPONSOR, LLC
	 
	 	 
	By:	 	 
	 	Name:	 
	 	Title:EXHIBIT 10.8

 

Execution
Version

 

THE SECURITIES DESCRIBED HEREIN HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION. THERE ARE FURTHER RESTRICTIONS
ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.

 

THE PURCHASE OF THE SECURITIES INVOLVES A HIGH
DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE LOSS OF THEIR ENTIRE INVESTMENT.

 

SUBSCRIPTION AGREEMENT

 

THIS
AGREEMENT (this “Agreement”), is dated as of April 6, 2021, by and between Innovatus Life Sciences
Acquisition Corp., a Delaware corporation (the “Company”), and Riverview Group II, Ltd. (“Subscriber”).

 

WHEREAS,
the Company was incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization
or similar business combination with one or more businesses (a “Business Combination”);

 

WHEREAS,
the Company will file with the U.S. Securities and Exchange Commission (the “SEC”) a registration statement on Form S-1
(the “Registration Statement”) for its initial public offering (“IPO”) of Class A common stock,
par value $0.0001 per share, (the “Public Shares”), at a price of $10.00 per Public Share;

 

WHEREAS,
proceeds from the IPO and the sale of the Private Placement Stock (as defined below) in an aggregate amount equal to the aggregate gross
proceeds from the IPO will be deposited into a trust account for the benefit of the holders of the Public Shares (the “Trust
Account”), as described in the Registration Statement;

 

WHEREAS,
following the closing of the IPO (the “IPO Closing”), the Company will seek to identify and consummate a Business Combination;

 

WHEREAS,
the Company and Innovatus Life Sciences Acquisition Sponsor, LLC, a Delaware limited liability company (the “Sponsor”),
have entered into, or intend to enter into, agreements concurrently with this Agreement (collectively, with this Agreement, the “Subscription
Agreements”) with certain affiliates of the Subscriber (together with the Subscriber, the “Subscribing Parties”),
in substantially the form of this Agreement, for the purchase of Founder Shares and Private Placement Stock set forth therein;

 

WHEREAS,
the Company, the Sponsor and the Subscribing Parties intend for the purchase of Founder Shares and Private Placement Stock as set forth
in the Subscription Agreements to be made pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities
Act”); and

 

WHEREAS,
the parties hereto desire that, upon the terms and subject to the conditions contained herein, the Company will sell to Subscriber, and
Subscriber shall purchase, (i) certain shares of Class B common stock of the Company (such purchased shares, the “Founder
Shares”) and (ii) certain shares of Class A common stock of the Company in a private placement transaction (such purchased
shares, the “Private Placement Stock”, and together with the Founder Shares, the “Securities”).

 

NOW,
THEREFORE, in consideration of the premises above, which are incorporated in this Agreement as if fully set forth below, and
the mutual covenants and other agreements contained in this Agreement, and for other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the Company and Subscriber hereby agree as follows:

 

		1.	Closing; Conditions.

 

(a)            Obligation.
Upon execution, Subscriber’s obligation to purchase the Securities, and the Company’s obligation to sell the Securities to
Subscriber in a private placement transaction (the “Private Placement”), shall be irrevocable, subject to the terms
set forth in this Agreement.

 

    

     

    

 

(b)            Closing.
The closing of the purchase of the Private Placement Stock (the “Private Placement Closing”) shall take place at the
offices of the Company, or such other place as determined by the Company (including remotely via delivery of electronic documents), contemporaneously
with the closing of the IPO (the “Private Placement Closing Date”). The closing of the purchase of the Founder Shares
(the “Founder Shares Closing”) shall take place at the offices of the Company, or such other place as determined by
the Company (including remotely via delivery of electronic documents), on the closing of the Business Combination (as defined below) (the
 “Founder Shares Closing Date”). As used herein, “Closing” means the Private Placement Closing or
the Founder Shares Closing, as applicable, and “Closing Date” means the Private Placement Closing Date or the Founder
Shares Closing Date, as applicable. If (i) the closing of the IPO has not occurred for any reason by July 31, 2021 or (ii) the
Company is liquidated or dissolved prior to the Founder Shares Closing Date, then, unless Subscriber otherwise agrees in writing, this
Agreement shall terminate and be of no further force or effect.

 

(c)            Closing
Conditions. Subscriber’s obligation to purchase the Securities and the Company’s obligation to sell the Securities to
Subscriber is conditioned upon satisfaction of the following conditions precedent (any or all of which may be waived by the Company or
Subscriber upon written notice of such waiver to the other party):

 

(i)            On
the applicable Closing Date, no legal, administrative or regulatory action, suit or proceeding shall be pending which seeks to restrain
or prohibit the transactions contemplated by this Agreement.

 

(ii)           The
representations and warranties of the Company and Subscriber contained in this Agreement shall have been true and correct on the date
of this Agreement and shall be true and correct on the applicable Closing Date as if made on such Closing Date.

 

(iii)           The
Sponsor and any of its affiliates shall have purchased at least seventy percent (70%) of the Private Placement Stock offered by the Company
in connection with the IPO which are not purchased by the Subscribing Parties.

 

(d)            Subscription
and Sale of the Securities. Subject to Section 1(f) hereof, (i) on the Private Placement Closing Date, Subscriber shall
purchase from the Company, and the Company shall issue and sell to Subscriber, the number of Private Placement Stock indicated on the
signature page hereof, in consideration for Subscriber’s purchase price for such Private Placement Stock indicated on the signature
page hereof (the “Private Placement Purchase Price”), on the terms and conditions described herein, and (ii) on
the Founder Shares Closing Date, (A) Subscriber shall purchase from the Company, and the Company shall sell to Subscriber, the number
of Founder Shares indicated on the signature page hereof, in consideration for Subscriber’s purchase price for such Founder
Shares indicated on the signature page hereof (the “Founder Shares Purchase Price” and, together with the Private
Placement Purchase Price, the “Purchase Price”) and (B) the Sponsor shall forfeit to the Company for cancellation,
for no consideration, and have no further right, title or interest in, an equal number of Founder Shares, on the terms and conditions
described herein. The number of Securities and the amount of the Purchase Price indicated on the signature page hereof may be increased
or decreased pursuant to Section 1(f) hereof.

 

(e)            Purchase
of the Securities. The Company shall notify Subscriber in writing of the anticipated date of the effectiveness of the Registration
Statement (as defined below) (the “Effective Date”) at least two (2) Business Days (as defined below) prior to
the Effective Date, and Subscriber shall remit the Private Placement Purchase Price to the Company’s transfer agent (to be held
in escrow pending the consummation of the IPO), by wire transfer of immediately available funds or other means approved by the Company,
on the date that is one (1) Business Day prior to the Effective Date, or such other date as the Company and Subscriber may agree
upon in writing. If the consummation of the IPO has not occurred for any reason by the date that is seven (7) Business Days after
the date on which Subscriber remitted the Private Placement Purchase Price to the Company’s transfer agent, then, unless Subscriber
otherwise agrees in writing, the Company shall promptly cause its transfer agent to return the Private Placement Purchase Price to Subscriber
without interest or deduction, and this Agreement shall terminate and thereafter have no force or effect. The Company shall notify Subscriber
in writing of the anticipated consummation date of the Business Combination at least two (2) Business Days prior to such date, and
the Company shall deliver the Founder Shares to or as instructed by Subscriber against payment of the Founder Shares Purchase Price to
accounts indicated by the Company by wire transfer of immediately available funds or other means approved by the Company, on the Founder
Shares Closing Date, or such other date as the Company and Subscriber may agree upon in writing. As used herein, “Business Day”
means any day, other than a Saturday or Sunday, that is neither a legal holiday nor a day on which banking institutions are generally
authorized or required by law or regulation to close in the City of New York, New York.

 

    2

     

    

 

(f)            Purchase
of Additional Securities; Return of Unused Amount of Purchase Price. It is currently contemplated that the IPO will raise $175,000,000
in gross proceeds (excluding exercise of the underwriter’s over-allotment option to purchase additional shares in the IPO). Subscriber
agrees that if the size of the IPO is increased or decreased for any reason, with such increase or decrease being at the Company’s
discretion, the amount of Subscriber’s investment (as indicated on the signature page hereof) will be either increased or decreased,
as applicable, so that Subscriber’s percentage of the aggregate investment in the Private Placement Stock made by Subscriber and
other investors of the Company remains the same. Likewise, the percentage of the Founder Shares to be sold to Subscriber compared to all
other holders of the Company’s Class B common stock will remain the same. The Company shall promptly notify Subscriber in writing
of any such increase or decrease in the size of the IPO.

 

		2.	Representations and Warranties of Subscriber.

 

Subscriber represents and
warrants as follows:

 

		(a)	(i)         Subscriber is an “accredited investor” as defined by Rule 501 under the Securities
Act of 1933, as amended (the “Securities Act”), as evidenced by the Accredited Investor Status Checklist (attached
hereto as Exhibit A) and has such knowledge and experience in financial and business matters that Subscriber is capable of
evaluating the merits and risks of Subscriber’s investment in the Securities, of making an informed investment decision with respect
thereto, and has the ability and capacity to protect Subscriber’s interests. Subscriber shall submit to the Company such further
assurances of accredited status as may reasonably be requested by the Company.

 

			(ii)        Subscriber understands that the
Company is relying on the accuracy of these representations and warranties and understands the significance of Subscriber’s representations
and warranties to the Company that Subscriber is an accredited investor. By executing this Agreement, Subscriber agrees to notify the
Company of any material changes affecting Subscriber’s status prior to the Company’s acceptance of the subscription.

 

(b)            Subscriber
understands that the Securities are not presently registered and the Company has no obligation to register the Securities or assist Subscriber
in obtaining an exemption from registration except as described in the registration statement relating to the IPO (“Registration
Statement”). Subscriber understands that the Private Placement Stock will not be registered under the Securities Act on the
basis that the issuance of the Private Placement Stock is exempt under either Section 4(a)(2) of the Securities Act or Regulation
D promulgated under the Securities Act as a transaction by an issuer not involving any public offering and that, in the view of the Securities
and Exchange Commission (the “SEC”), the statutory basis for the exemption claimed may not be present if any of the
representations and warranties of Subscriber contained in (a) through (d) of this Section 2 are untrue or, notwithstanding
Subscriber’s representations and warranties, Subscriber currently contemplates acquiring any of the Securities for resale.

 

(c)            Subscriber
is purchasing and acquiring the Securities for investment purposes and not with a view to distribution or resale, nor with the intention
of selling, transferring or otherwise disposing of all or any part thereof for any particular price, or at any particular time, or upon
the happening of any particular event or circumstance, except selling, transferring, or disposing the Securities made in full compliance
with all applicable provisions of the Securities Act, the rules and regulations promulgated by the SEC thereunder, and applicable
state securities laws; and Subscriber understands that an investment in the Securities is not a liquid investment.

 

(d)            Subscriber
acknowledges that there exists no public market for the Securities, that no such public market may develop in the future, the Securities,
when sold or issued, will be “restricted securities” and as a result, Subscriber acknowledges that the Securities may be required
to be held indefinitely unless subsequently registered under the Securities Act or unless an exemption from such registration is available.
Subscriber is aware of the provisions of Rule 144 promulgated under the Securities Act which permit resales of securities purchased
in a private placement subject to certain limitations and to the satisfaction of certain conditions provided for thereunder, including,
among other things, the existence of a public market for the securities, the availability of certain current public information about
the company issuing the securities, the resale occurring not less than six months after a party has purchased and paid for the security
to be sold, the sale being effected through a “broker’s transaction” or in transactions directly with a “market
maker” and the number of securities being sold during any three-month period not exceeding specified limitations. Subscriber further
acknowledges that the Securities will be subject to certain lock-up restrictions, as described in this Agreement, and may only be transferred
pursuant to the terms of such lock-up. Subscriber also acknowledges that Rule 144 is not available for the resale of securities initially
issued by shell companies or issuers that have been at any time previously a shell company and that Rule 144 will provide an exception
to this prohibition only if (i) the Company has then ceased to be a shell company; (ii) the Company is then subject to the reporting
requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act”);
(iii) the Company has then filed all Exchange Act reports and material required to be filed, as applicable, during the preceding
12 months (or such shorter period that the Company was required to file such reports and materials), other than Form 8-K reports;
and (iv) at least one year has elapsed from the time that the Company filed current Form 10 type information with the SEC reflecting
its status as an entity that is not a shell company.

 

    3

     

    

 

(e)            Subscriber
acknowledges that Subscriber has had the opportunity to ask questions of, and receive answers from the Company or any authorized person
acting on its behalf concerning the Company’s proposed business plan and to obtain any additional information, to the extent possessed
by the Company (or to the extent it could have been acquired by the Company without unreasonable effort or expense) necessary to verify
the accuracy of the information received by Subscriber. In connection therewith, Subscriber acknowledges that Subscriber has had the opportunity
to discuss the Company’s proposed business, management and financial affairs with the Company’s management or any authorized
person acting on its behalf. Subscriber has received and reviewed all the information concerning the Securities and the Company’s
business, management, financial affairs, prospects and risks, both written and oral, that Subscriber desires. In determining whether to
make this investment, Subscriber has relied solely on (i) Subscriber’s own knowledge and understanding of the Company and its
proposed business based upon Subscriber’s own due diligence investigations and the information furnished pursuant to this paragraph,
(ii) the information described in subparagraph 2(g) below and (iii) the representations and warranties of the Company made
to Subscriber in this Agreement.

 

(f)            Subscriber
has all requisite legal and other power and authority to execute and deliver this Agreement and to carry out and perform Subscriber’s
obligations under the terms of this Agreement. This Agreement constitutes a valid and legally binding obligation of Subscriber, enforceable
in accordance with its terms, subject to laws of general application relating to bankruptcy, insolvency and the relief of debtors and
rules of law governing specific performance, injunctive relief or other general principals of equity, whether such enforcement is
considered in a proceeding in equity or law.

 

(g)            Subscriber
has carefully considered and has discussed with Subscriber’s legal, tax, accounting and financial advisors, to the extent Subscriber
has deemed necessary, the suitability of this investment and the transactions contemplated by this Agreement for Subscriber’s particular
federal, state, local and foreign tax and financial situation and has independently determined that this investment and the transactions
contemplated by this Agreement are a suitable investment for Subscriber. Subscriber has relied solely on such advisors and not on any
statements or representations of the Company or any of its agents. Subscriber understands that Subscriber (and not the Company) shall
be responsible for Subscriber’s own tax liability that may arise as a result of this investment or the transactions contemplated
by this Agreement.

 

(h)            There
are no actions, suits, proceedings or investigations pending against Subscriber or Subscriber’s assets before any court or governmental
agency (nor, to Subscriber’s knowledge, is there any threat thereof) which would impair in any way Subscriber’s ability to
enter into and fully perform Subscriber’s commitments and obligations under this Agreement or the transactions contemplated hereby.

 

(i)            The
execution, delivery and performance of and compliance with this Agreement and the sale and issuance of the Securities will not result
in any violation of, or conflict with, or constitute a default under, any of Subscriber’s articles of incorporation, by-laws, operating
agreement, partnership agreement, or trust agreement, if applicable, or any agreement to which Subscriber is a party or by which it is
bound.

 

(j)            Subscriber
acknowledges that an investment in the Securities is speculative and involves a high degree of risk and that Subscriber can bear the economic
risk of the purchase of the Securities, including a total loss of its investment. Subscriber acknowledges and understands and agrees that
in the event the Company is unable to consummate an initial merger, stock exchange, asset acquisition or other similar business combination
(the “Business Combination”) within a certain period of time following the closing of the IPO, then Subscriber may
lose its entire investment.

 

    4

     

    

 

(k)           Subscriber
understands that the officers and directors of the Company, and other similarly situated individuals, may receive better terms than those
being offered to Subscriber hereby, which have been disclosed to Subscriber.

 

(l)            Subscriber
recognizes that no federal, state or foreign agency has reviewed, recommended or endorsed the purchase of the Securities or any facts
or circumstances related thereto.

 

(m)          Subscriber
is aware that (i) the Company will have no operations and no commitments for any additional capital that may be needed in the future
and (ii) the Company will be a shell company. Subscriber has experience in evaluating the risks of investing in early stage development
companies and blank check companies.

 

(n)          Subscriber
represents that Subscriber is not purchasing or acquiring the Securities as a result of or subsequent to any advertisement, article, notice
or other communication published in any newspaper, magazine or similar media or broadcast over the Internet, television or radio or presented
at any seminar or meeting or any public announcement or filing of or by the Company or any of its affiliates, agents or representatives.

 

(o)          Subscriber
has carefully read each of the terms and provisions of this Agreement.

 

(p)          No
representations or warranties have been made to Subscriber by the Company or any officer, employee, agent, affiliate or subsidiary of
the Company, other than the representations of the Company contained herein, and in purchasing the Founders Shares and subscribing for
the Private Placement Stock, Subscriber is not relying upon any representations other than those contained in this Agreement. Subscriber
has not been furnished with any oral representation or oral information in connection with or in any way relating to the Private Placement
or the proposed business or prospects of the Company.

 

(q)          Subscriber
represents and warrants it has not engaged any finder, broker, agent, financial advisor or other intermediary, nor any purchaser representative
or any broker-dealer acting as a broker, that is entitled to any compensation in connection with the transactions contemplated by this
Agreement.

 

(r)           Subscriber
acknowledges that if the Company does not complete an initial Business Combination within the required time period, (i) the assets
in the Company’s trust account, including any remaining proceeds of the sale of the Private Placement Stock, will be used to fund
the redemption of its public shares and (ii) that there will be no liquidating distributions from the Company’s trust account
with respect to the Securities held by the Sponsor, and the Private Placement Stock will expire worthless.

 

		3.	Representations and Warranties of the Company.

 

The Company represents and
warrants as follows:

 

(a)            Organization.
The Company is duly organized and validly existing as a Delaware corporation.

 

(b)            Corporate
Power. The Company has the power and authority to enter into, deliver and perform this Agreement and the agreements to be entered
into therewith.

 

(c)            Authorization.
All necessary action has been duly and validly taken by the Company to authorize the execution, delivery and performance of this Agreement
by the Company, and the issuance and sale of the Private Placement Stock to be sold by the Company pursuant to this Agreement. This Agreement
has been duly and validly authorized, executed and delivered by the Company and constitutes the legal, valid and binding obligation of
the Company enforceable against the Company in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and by general
equitable principles.

 

    5

     

    

 

(d)            Capitalization.
The authorized share capital of the Company consists of, as of the date hereof:

 

(i)            100,000,000
shares of Class A common stock, none of which are issued and outstanding;

 

(ii)           10,000,000
shares of Class B common stock, 5,031,250 of which are issued and outstanding. All of the outstanding shares of Class B common
stock have been duly authorized, are fully paid and nonassessable and were issued in compliance with all applicable federal and state
securities laws; and

 

(iii)          1,000,000
shares of preferred stock, none of which are issued and outstanding.

 

(e)            Valid
Issuance of Private Placement Stock. The Private Placement Stock, when issued, sold and delivered in accordance with the terms and
for the consideration set forth in this Agreement:

 

(i)            will
be free and clear of any preemptive or similar rights, taxes, security interests, liens, claims or other encumbrances, subject only to
restrictions upon transfer specified under this Agreement, the Securities Act and any applicable state securities laws;

 

(ii)           will
be duly and validly issued, fully paid and non-assessable;

 

(iii)          will
not subject the holders thereof to personal liability by reason of being such holders; and

 

(iv)          assuming
the representations and warranties of Subscriber as set forth in Section 2 hereof are true and correct, will not result in a violation
of Section 5 under the Securities Act.

 

No “bad actor”
disqualifying event described in Rule 506(d)(1)(i)-(viii) of the Securities Act (a “Disqualification Event”)
is applicable to the Company or, to the Company’s knowledge, any Company Covered Person (as defined below), except for a Disqualification
Event as to which Rule 506(d)(2)(ii)-(iv) or (d)(3), is applicable. “Company Covered Person” means, with
respect to the Company as an “issuer” for purposes of Rule 506 promulgated under the Securities Act, any person listed
in the first paragraph of Rule 506(d)(1).

 

(f)            IPO.
The offers and sales of securities in the IPO will be made pursuant to an effective Registration Statement and otherwise in compliance
with the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws, rules and
regulations.

 

(g)            No
General Solicitation. Neither the Company, nor to its knowledge, any person acting on its or their behalf, has engaged in any form
of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act) in connection with the offer
or sale of the Private Placement Stock.

 

(h)            Governmental
Consents and Filings. Assuming the accuracy of Subscriber’s representations and warranties set forth in Section 2 and in
the Accredited Investor Status Checklist attached hereto, no consent, approval, order or authorization of, or registration, qualification,
designation, declaration or filing with, any federal, state or local governmental authority is required on the part of the Company in
connection with the consummation of the transactions contemplated by this Agreement, except for filings pursuant to Regulation D of the
Securities Act and applicable state securities laws, if any.

 

(i)            Compliance
with Other Instruments. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
by this Agreement will not result in any violation or default (i) under any provisions of the certificate of incorporation, bylaws
or other governing documents of the Company, (ii) under any instrument, judgment, order, writ or decree to which the Company is a
party or by which it is bound, (iii) under any note, indenture or mortgage to which the Company is a party or by which it is bound,
(iv) under any lease, agreement, contract or purchase order to which the Company is a party or by which it is bound or (v) under
any provision of federal or state statute, rule or regulation applicable to the Company, in each case (other than clause (i)) which
would have a material adverse effect on the Company or its ability to consummate the transactions contemplated by this Agreement.

 

    6

     

    

 

(j)            Compliance
with Laws. The Company has complied and shall at all times comply with all federal,
state, and local laws, ordinances, regulations, and orders that are applicable to the operation of its business and to this Agreement
and its performance hereunder, except to the extent that failure to comply would not have a material adverse effect on its business or
its ability to comply with its obligations under this Agreement.

 

(k)            Operations.
As of the date hereof, the Company has not conducted, and prior to the consummation of the IPO the Company will not conduct, any operations
other than organizational activities and activities in connection with offerings of the Securities.

 

(l)            Foreign
Corrupt Practices. Neither the Company, nor any director, officer, agent, employee or other person acting on behalf of the Company
has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any unlawful contribution, gift,
entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any
foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation of any provision of the
U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback
or other unlawful payment to any foreign or domestic government official or employee.

 

(m)           Compliance
with Anti-Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations,
including, but not limited to, those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the USA Patriot Act of
2001 and the applicable money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related
or similar rules, regulations or guidelines, issued, administered or enforced by any governmental agency (collectively, the “Anti-Money
Laundering Laws”), and no action, suit or proceeding by or before any court or governmental agency, authority or body or any
arbitrator involving the Company with respect to the Anti-Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

(n)            Absence
of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public board, government agency,
self-regulatory organization or body pending or, to the knowledge of the Company, threatened against or affecting the Company or any of
the Company’s officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as such.

 

(o)           Non-Public
Information. The Company represents and warrants that it will use its best efforts to ensure that none of the information conveyed
to Subscriber in connection with the transactions contemplated by this Agreement will constitute material non-public information of the
Company upon the effectiveness of the Registration Statement.

 

		4.	Additional Agreements.

 

(a)            Lockup.

 

(i)            Subscriber
agrees with the Company that (i) the Founder Shares may not be transferred, assigned or sold until the earlier to occur of: (A) one
year after the consummation of the Business Combination and (B) the date following the completion of the Business Combination on
which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of its shareholders
having the right to exchange their shares of common stock for cash, securities or other property and (ii) the Private Placement Stock
(or any shares of common stock issuable upon exercise of the Private Placement Stock) may not be transferred, assigned or sold until 30
days after the consummation of the Business Combination. Notwithstanding the foregoing, if the closing price of the Company’s common
stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like)
for any 20 trading days within any 30-trading day period commencing at least 150 days after the Business Combination, the Founder Shares
will be released from the lockup. If at any time, and for any reason, the Sponsor, or any other subscriber of Founder Shares or Private
Placement Stock, receives terms more favorable than the restrictions contained in this Section 4(a) (the “Lock-Up Restrictions”),
then such terms shall be equally applied to Subscriber’s Founder Shares and/or Private Placement Stock, as applicable, and the Lock-Up
Restrictions contained herein shall be amended, without any further required action of the parties hereto, to reflect the more favorable
Lock-Up Restrictions provided to the Sponsor or such other subscriber of Founder Shares and/or Private Placement Stock. The Securities
shall contain a legend reflecting the foregoing lockup. Notwithstanding the first sentence hereinabove, transfers, sales and assignments
of the Securities are permitted (i) to the Company’s officers or directors, any affiliates or family members of any of the
Company’s officers or directors, the Sponsor, any affiliate of the Sponsor, any members of the Sponsor, or any of their affiliates,
officers, directors, direct and indirect equityholders; (ii) in the case of an individual, by gift to a member of such individual’s
immediate family or to a trust, the beneficiary of which is a member of such individual’s immediate family, an affiliate of such
person or to a charitable organization; (iii) in the case of an individual, by virtue of laws of descent and distribution upon death
of the individual; (iv) in the case of an individual, pursuant to a qualified domestic relations order; (v) private sales or
transfers made in connection with the consummation of a Business Combination at price no greater than the price at which the applicable
Securities were originally purchased; (vi) in the event of the Company’s liquidation prior to the completion of a Business
Combination; (vii) to Subscriber’s affiliates, or any investment fund or other entity controlled or managed by Subscriber,
or to any investment manager or investment advisor of such Subscriber or an affiliate of any such investment manager or investment advisor
or to any investment fund or other entity controlled or managed by such persons (each of the foregoing, a “Permitted Transferee”);
provided, however, that in the case of clauses (i) through (v) and (vii), these Permitted Transferees must enter
into a written agreement agreeing to be bound by the terms of this Agreement, including these transfer restrictions.

 

    7

     

    

 

(ii)            Following
the expiration of the transfer restrictions set forth in clause (i) above, if the Securities are eligible to be sold without restriction
under, and without the Company being in compliance with the current public information requirements of, Rule 144 under the Securities
Act, or if they are registered for resale under the Securities Act pursuant to a shelf registration statement, then at Subscriber’s
written request, the Company will use commercially reasonable efforts to cause the Company’s transfer agent to remove the legend
referred to in clause (i) above, subject to compliance by Subscriber with the reasonable and customary procedures for such removal
required by the Company or its transfer agent. In connection therewith, if required by the Company’s transfer agent, the Company
will promptly cause an opinion of counsel to be delivered to and maintained with its transfer agent, together with any other authorizations,
certificates and directions required by the transfer agent that authorize and direct the transfer agent to issue such Securities without
any such legend.

 

(b)            Registration
Rights. The Company and Subscriber will enter into a registration rights agreement on the Effective Date substantially in the form
provided to Subscriber prior to the date hereof granting Subscriber customary registration rights with respect to the Founder Shares and
Private Placement Stock as described in the Registration Statement.

 

(c)            Reduction
If Subscriber Exercises Redemption Rights or Sells Shares. Subscriber acknowledges and agrees that the number of Founder Shares to
be sold to Subscriber shall be reduced (and the Founder Shares Purchase Price shall be decreased accordingly) if Subscriber holds less
than the sum of (i) the number of shares of Class A common stock allocated to Subscriber in the IPO and (ii) the number
of shares of Class A common stock purchased by Subscriber in the Private Placement (collectively, the “Required Number”)
on the closing date of the Business Combination. Notwithstanding the foregoing, in no event shall the Required Number exceed the Beneficial
Ownership Limitation (as defined below) as of the Closing Date. The number of Founders Shares will be reduced pro rata by a fraction,
(i) the numerator of which shall equal the Required Number less the number of shares of Class A common stock held by Subscriber
after giving effect to any redemptions of the shares of Class A common stock by Subscriber, and (ii) the denominator of which
shall equal the Required Number.

 

(d)            Changes
in Connection with the Business Combination. Subscriber agrees that if, in connection with a
Business Combination, the Sponsor decides (i) to forfeit, transfer to a third person, exchange, subject to transfer, vesting or conditional
forfeiture provisions, or amend the terms of all or any portion of the Founder Shares and/or the Private Placement Stock (or the Sponsor’s
membership interests representing an interest in any of the foregoing) or (ii) to enter into any other arrangements with respect
to the Founder Shares and/or the Private Placement Stock (or the Sponsor’s membership interests representing an interest in any
of the foregoing), to facilitate the consummation of such Business Combination (each, a “Change in Investment”),
such Change in Investment shall apply (i) pro rata to the Founder Shares held by the Sponsor and Subscriber based on the relative
number of Founder Shares to be held by each on the Founder Shares Closing Date; provided, however, that in no event
shall such Change in Investment apply to more than 50% of the Founder Shares to be purchased by Subscriber and (ii) 50% of the Private
Placement Stock held by the Sponsor and the Private Placement Stock held by Subscriber based on the relative number of Private Placement
Stock to be held by each on the Founder Shares Closing Date; and provided that in each case Subscriber has been given notice at least
two (2) Business Days prior to any proposed Change in Investment. Subscriber agrees to take all steps and execute all such agreements
as may be necessary or reasonably requested by the Sponsor to effectuate such Change in Investment on the same terms as applicable to
the Sponsor. If the Sponsor or any affiliate of the Sponsor enters into any agreement that gives such person the right, on an absolute
or contingent basis, to restore the value or original terms of any Founder Shares and/or Private Placement Stock that were the subject
of any such Change in Investment, or to receive any other consideration, then the Subscriber shall be provided the same rights on a pro
rata basis.

 

    8

     

    

 

(e)            Automatic
Conversion of Founder Shares. The Founder Shares acquired by Subscriber shall automatically convert into Class A Common stock
of the Company on the Business Day following the closing of the Business Combination. For the avoidance of doubt, Subscriber shall be
prohibited from converting any acquired Founder Shares prior to the consummation of the Business Combination.

 

(f)            Right
to Participate in Future Offerings; Favorable Terms. In the event the Company contemplates an additional offering of securities in
anticipation of the Business Combination, the Company shall offer the Subscriber (together with any of its Permitted Transferees), the
right to participate in such offering in the same percentages subscribed or purchased by the Company at the time of the IPO Closing. Additionally,
if the Company grants any person or entity (other than the individuals described
in Section 2(k) of this Agreement) any rights with respect to the registration of any shares of equity securities of the Company
or any securities convertible or exercisable into shares of any equity securities of the Company that are more favorable to such person
than the rights of the Holder set forth in this Subscription Agreement, then the Company shall grant to Subscriber the same rights granted
to such other person or entity.

 

(g)            Material
Non-Public Information. The Company agrees that, in the event it intends to provide information to Millennium that could reasonably
be considered material non-public information of a registered or listed issuer or which could reasonably be expected to cause Millennium
to restrict trading activities, the Company shall first obtain the written consent of Millennium’s General Counsel or Chief Compliance
Officer, or such other persons notified to the Company in writing by either of them before providing such information to Millennium, and
shall provide such information only to such persons. The Company shall not provide such information to any other personnel of Millennium
without the prior written consent of Millennium’s General Counsel or Chief Compliance Officer.

 

(h)            Independent
Nature of Rights and Obligations. Nothing contained herein, and no action taken by any party pursuant hereto, shall be deemed to constitute
Subscriber and the Sponsor as, and the Sponsor acknowledges that Subscriber and the Sponsor do not so constitute, a partnership, an association,
a joint venture or any other kind of entity, or create a presumption that Subscriber and the Sponsor are in any way acting in concert
or as a group with respect to such obligations or the transactions contemplated by this Agreement or any matters, and the Sponsor acknowledges
that Subscriber and the Sponsor are not acting in concert or as a group, and the Sponsor shall not assert any such claim, with respect
to such obligations or the transactions contemplated by this Agreement.

 

(i)            Waiver
of Rights in Trust Account. Subscriber hereby agrees that it shall have no right of set-off or any right, title, interest or claim
of any kind (“Claim”) to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies
in, the Trust Account that it may have now or in the future, except for redemption and liquidation rights, if any, Subscriber may have
in respect of any Public Shares held by it. In the event Subscriber has any Claim against the Company under this Agreement, Subscriber
shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the property or any monies
in the Trust Account, except for redemption and liquidation rights, if any, Subscriber may have in respect of any Public Shares held by
it.

 

(j)            Use
of Subscriber’s Name. Neither the Company nor the Sponsor will, without the written consent of Subscriber in each instance,
use in advertising, publicity or otherwise the name of Subscriber or any of its affiliates, or any director, officer or employee of Subscriber,
nor any trade name, trademark, trade device, service mark, symbol or any abbreviation, contraction or simulation thereof owned by Subscriber
or its affiliates or any information relating to the business or operations of Subscriber or its affiliates (including, for the avoidance
of doubt, any investment vehicles, funds or accounts managed thereby). Notwithstanding the foregoing, the Company may disclose Subscriber’s
name and information concerning Subscriber (A) to the extent required by law, regulation or regulatory request, (B) in the Registration
Statement or (C) to the Company’s lawyers, independent accountants and to other advisors and service providers who reasonably
require Subscriber’s information in connection with the provision of services to the Company, are advised of the confidential nature
of such information and are obligated to keep such information confidential. The Company and the Sponsor agree to provide to Subscriber
for Subscriber’s review any disclosure in any registration statement, proxy statement or other document in advance of the submission,
filing or disclosure of such document in connection with the transactions contemplated by this Agreement with respect to Subscriber or
any of its affiliates, and will not make any such submission, filing or disclosure without including any revisions reasonably requested
in writing by Subscriber or to the extent Subscriber has a good faith objection to such submission, filing or disclosure.

 

    9

     

    

 

(i)            Beneficial
Ownership Limitation. Notwithstanding anything to the contrary herein, none of the rights of Subscriber provided for herein, shall
result in Subscriber (together with any affiliates of Subscriber, and any persons or entities acting as a group together with Subscriber
or any affiliates of Subscriber) beneficially owning in excess of the Beneficial Ownership Limitation. Beneficial ownership shall be calculated
in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
and the rules and regulations promulgated thereunder. The “Beneficial Ownership Limitation” shall mean 9.9% of the number
of shares of Class A common stock of the Company or any other class of securities that would be subject to Section 16 under
the Exchange Act or the rules and regulations promulgated thereunder.

 

(k)            Prohibition
on Certain Business Combinations. The Company shall not enter into a business combination where the resultant company of such business
combination would be classified as a U.S. Real Property Holding Corporation under Section 897 of the Internal Revenue Code of 1986,
as amended.

 

		5.	Miscellaneous.

 

(a)            Notices.
Any notice or other document required or permitted to be given or delivered to the parties hereto shall be in writing and sent: (i) by
registered or certified mail with return receipt requested (postage prepaid) or (ii) by a recognized overnight delivery service (with
charges prepaid).

 

If to the Company, at:

 

Innovatus Life Sciences Acquisition
Corp.

777 Third Avenue, 25th Floor

New York, New York 10017

Attention: Chief Financial
Officer

 

With a copy, which shall not
constitute notice, to:

 

Ellenoff Grossman &
Schole LLP

1345 Avenue of the Americas,
11th Floor

New York, New York 10105

Attention: Douglas S. Ellenoff

 

If to Subscriber at:

 

c/o Millennium Management
LLC

666 Fifth Avenue, 8th
Floor

New York, New York 10103

Attention: General Counsel

 

With a copy, which shall not
constitute notice, to:

 

White & Case LLP

1221 Avenue of the Americas,
45th Floor

New York, New York 10020

Attention: Joel Rubinstein

 

    10

     

    

 

(b)            Entire
Agreement; Amendments; Assignment. This Agreement, together with any other documents, instruments and writings that are delivered
pursuant hereto or referenced herein, represents the entire agreement between the parties hereto with respect to the subject matter hereof
and supersedes all prior understandings, agreements or representations by or among the parties hereto, written or oral, to the extent
they relate in any way to the subject matter hereof of the transactions contemplated hereby. This Agreement may be terminated, modified,
waived or amended only by a writing executed and delivered by both parties. No right or obligation of a party shall be assigned or otherwise
transferred without prior notice to and the written consent of the other party. Any assignment or transfer in violation of the foregoing
shall be null and void.

 

(c)            Counterparts/Execution.
This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate counterparts, each of
which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the same instrument. This
Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic means with the same force and
effect as if such signature page were an original thereof.

 

(d)            Law
Governing this Agreement. This Agreement, the entire relationship of the parties hereto, and any litigation between the parties (whether
grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the
laws of the State of New York, without giving effect to its choice of law principles.

 

(e)            Successors.
All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to
the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in this Agreement, express or implied,
is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f)            WAIVER
OF JURY TRIAL. EACH PARTY HERETO (INCLUDING ITS AFFILIATES, AGENTS, OFFICERS, DIRECTORS AND EMPLOYEES) HEREBY IRREVOCABLY WAIVES,
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

(g)            Specific
Enforcement; Consent to Jurisdiction. The Company and Subscriber acknowledge and agree that irreparable damage would occur in the
event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were otherwise breached.
It is accordingly agreed that the parties hereto shall be entitled to seek an injunction or injunctions to prevent or cure breaches of
the provisions of this Agreement and to enforce specifically the terms and provisions hereof, this being in addition to any other remedy
to which any of them may be entitled by law or equity. The parties hereby irrevocably and unconditionally (i) submit to the jurisdiction
of the state courts of New York and the United States District Court for the Southern District of New York for the purpose of any suit,
action or other proceeding arising out of or based upon this Agreement, (ii) agree not to commence any suit, action or other proceeding
arising out of or based upon this Agreement except in state courts of New York or the United States District Court for the Southern District
of New York, and (iii) waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action or
proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or
immune from attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit,
action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court.

 

(h)            Drafting.
This Agreement shall not be construed for or against a party based upon authorship.

 

(i)            Captions;
Certain Definitions. The captions of the various sections and paragraphs of this Agreement have been inserted only for the purposes
of convenience; such captions are not a part of this Agreement and shall not be deemed in any manner to modify, explain, enlarge or restrict
any of the provisions of this Agreement. As used in this Agreement the term “person” shall mean and include an individual,
a partnership, a joint venture, a corporation, a limited liability company, a trust, an unincorporated organization or any other legal
entity and a government or any department or agency thereof.

 

    11

     

    

 

(j)            Severability.
In the event that any term or provision of this Agreement shall be finally determined to be superseded, invalid, illegal or otherwise
unenforceable pursuant to applicable law by an authority having jurisdiction and venue, that determination shall not impair or otherwise
affect the validity, legality or enforceability: (i) by or before that authority of the remaining terms and provisions of this Agreement,
which shall be enforced as if the unenforceable term or provision were deleted, or (ii) by or before any other authority of any of
the terms and provisions of this Agreement.

 

(k)            Expenses.
Each of the Company and Subscriber will bear its own costs and expenses incurred in connection with the preparation, execution and performance
of this Agreement and the consummation of the transactions contemplated hereby, including all fees and expenses of agents, representatives,
financial advisors, legal counsel and accountants. The Company shall be responsible for the fees of its transfer agent, stamp taxes and
all of The Depository Trust Company’s fees associated with the issuance of the Securities and the securities issuable upon conversion
or exercise of the Securities.

 

(l)            Confidentiality.
Except as may be required by law, regulation or applicable stock exchange listing requirements (but subject in any case to the provisions
of Section 4(j) hereof), unless and until the transactions contemplated hereby and the terms hereof are publicly announced
or otherwise publicly disclosed by the Company, the parties hereto shall keep confidential and shall not publicly disclose the existence
or terms of this Agreement. Notwithstanding the foregoing, Subscriber shall be permitted to disclose any information to its affiliates
and its and their respective directors, officers, employees, advisors, director or indirect owners, agents and representatives, in each
case so long as such person or entity has been advised of the confidentiality obligations hereunder; provided that Subscriber shall be
liable for any breach of such confidentiality obligations by any such person or entity.

 

(m)            Survival
of Representations and Warranties. All of the representations and warranties contained herein shall survive the consummation of the
transactions contemplated by this Agreement.

 

(Signature pages follow.)

 

    12

     

    

 

IN WITNESS WHEREOF, Subscriber
has caused this Agreement to be executed as of the date indicated below.

 

	 	SUBSCRIBER:
	 	 
	 	RIVERVIEW GROUP II, LTD.
	 	 
	 	By: Millennium Management, LLC
	 	its Investment Manager
	 	 
	 	By:	/s/ Mark Meskin
	 	Name:	Mark Meskin
	 	Title:	Chief Trading Officer

 

Date: April 6, 2021

 

	Number of shares of Private Placement Stock to be purchased at $10.00 per share	 	 	58,500	 
	Purchase price for Private Placement Stock	 	$	585,000	 
	Number of Founder Shares to be sold at approximately $0.006 per share	 	 	374,000	 
	Purchase Price for Founder Shares	 	$	2,140	 
	Purchase Price	 	$	587,140	 

 

[Signature Page to Subscription Agreement]

 

    

     

    

 

Acceptance and Agreement:

 

IN WITNESS WHEREOF, the Company
has caused this Agreement to be executed, and the foregoing subscription accepted and agreed to, as of the date indicated below.

 

	 	COMPANY:
	 	 
	 	INNOVATUS LIFE SCIENCES ACQUISITION CORP.
	 	 
	 	By:	/s/ Andrew Hobson
	 	Name:	Andrew Hobson
	 	Title:	Chief Financial Officer

 

Date: April 6, 2021

 

[Signature Page to Subscription Agreement]

 

    

     

    

 

Exhibit A
 – Accredited Investor Questionnaire

 

SUBSCRIBER TO COMPLETE

 

Accredited Investor Status Checklist:

 

Please check one or more of the following definitions
of “accredited investor,” if any, which applies to you. If none of the following applies to you, you may not qualify to take
parting this offering.

 

	 ̈	A Bank as defined in Section 3(a)(2) of the Securities Act, or any savings association or institution as defined in Section 3(a)(5)(A) of the Securities Act.
	 	 
	 ̈	Any broker or dealer registered pursuant to Section 15 of the Exchange Act.
	 	 
	 ̈	An insurance company as defined in Section 2(13) of the Securities Act.
	 	 
	 ̈	Investment company registered under the Investment Company Act of 1940, as amended (the “Investment Company Act”) or a business development company as defined in Section 2(a)(48) of the Investment Company Act.
	 	 
	 ̈	Small Business Investment Company licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958, as amended.
	 	 
	 ̈	Plan established and maintained by a state, or its political subdivisions, or any agency or instrumentality of a state or its political subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000.
	 	 
	 ̈	Any employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974, as amended, if the investment decision is made by a plan fiduciary, as defined in the Securities Act, which is either a bank, savings and loan association, insurance company, or registered investment advisor, or if the plan has assets in excess of $5,000,000 or, if a self-directed plan, with investment decisions made solely by persons that are Accredited Investors.
	 	 
	 ̈	A Private Business Development Company as defined in Section 202(a)(22) of the Investment Advisers Act of 1940, as amended.
	 	 
	 ̈	An organization described in Section 501(c)(3) of the Internal Revenue Code, a corporation, business trust, partnership, or limited liability company, or any other entity, not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000.

 

	 ̈	
    A natural person whose individual net worth, or
    joint net worth with that person’s spouse, at the time of purchase exceeds $1,000,000.

     

    The term
    “net worth” means the excess of total assets over total liabilities (including personal and real property, but excluding the
    estimated fair market value of Subscriber’s primary home). For the purposes of calculating joint net worth with the person’s
    spouse or spousal equivalent, joint net worth can be the aggregate net worth of Subscriber and spouse or spousal equivalent; assets need
    not be held jointly to be included in the calculation. There is no requirement that securities be purchased jointly. A spousal equivalent
    means a cohabitant occupying a relationship generally equivalent to a spouse.

     

 

Accredited Investor Questionnaire

 

    

     

    

 

	 ̈	
    A natural person who had an individual income
    in excess of $200,000 in each of the two most recent years or joint income with that person’s spouse or spousal equivalent in excess
    of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current year.

     

    For purposes hereof the term “income”
    is not limited to “adjusted gross income” as that term is defined for federal income tax purposes, but rather includes certain
    items of income which are deducted in computing “adjusted gross income.” For investors who are salaried employees, the gross
    salary of such investor, minus any significant expenses personally incurred by such investor in connection with earning the salary, plus
    any income from any other source including unearned income, is a fair measure of “income” for purposes hereof. For investors
    who are self-employed, “income” is generally construed to mean total revenues received during the calendar year minus significant
    expenses incurred in connection with earning such revenues.

	 	 
	 ̈	A trust, with assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Securities, whose purchase is directed by a sophisticated person as described in Rule 506(b)(2) (ii) of Regulation D of the Securities Act.
	 	 
	 ̈	Any entity in which all of the equity owners are Accredited Investors.
	 	 
	 ̈	A director or officer of the Company.

                                                                       

	 ̈	A natural person holding in good standing
with one or more professional certifications or designations or other credentials from an accredited educational institution that the
U.S. Securities Exchange Commission (“SEC”) has designated as qualifying an individual for accredited investor status; 

	 	 
	 	The
SEC has designated the General Securities Representative license (Series 7), the Private Securities Offering Representative license (Series
82) and the Licensed Investment Adviser Representative (Series 65) as the initial certifications that qualify for accredited investor
status.

 

	 	 
	 ̈	A natural person who is a “knowledgeable employee” as defined in Rule 3c-5(a)(4) under the Investment Company Act, of the issuer of the securities being offered or sold where the issuer would be an investment company, as defined in section 3 of the Investment Company Act, but for the exclusion provided by either section 3(c)(1) or section 3(c)(7) of the Investment Company Act;

                                                                       

	 ̈	
    An investment adviser registered pursuant to section
    203 of the Investment Advisers Act of 1940 (the “Investment Advisers Act”) or registered pursuant to the laws of a
    state, or an investment adviser relying on the exemption from registering with the SEC under the section 203(l) or (m) of the
    Investment Advisers Act;

     

	 ̈	
    A Rural Business Investment Company as defined
    in section 384A of the Consolidated Farm and Rural Development Act;

     

	 ̈	
    A “family office” as defined in Rule 202(a)(11)(G)-1
    under the Investment Advisers Act with assets under management in excess of $5,000,000 that is not formed for the specific purpose of
    acquiring the securities offered and whose prospective investment is directed by a person who has such knowledge and experience in financial
    and business matters that such family office is capable of evaluating the merits and risks of the prospective investment;

     

	 ̈	A “family client” as defined in Rule 202(a)(11)(G)-1 under the Investment Advisers Act, of a family office meeting the requirements set forth in the preceding row and whose prospective investment in the issuer is directed by a person from a family office that is capable of evaluating the merits and risks of the prospective investment;

 

Accredited
Investor Questionnaire

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]